There is a Phase III clinical trial study being conducted to evaluate the safety and efficacy of clobazam as adjunctive therapy in the treatment of seizures which lead to drop attacks/seizures in subjects 2 to 60 years of age with Lennox-Gastaut Syndrome. There are 65 sites in the US enrolling subjects in the study.  For more information on the study and how to enroll go to the links section of the PACE website, click on the clinicaltrials.gov link , click search for clinical trial, type in pediatric epilepsy. It is study 13.